Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis

Sathasivam, 2001, Apoptosis in amyotrophic lateral sclerosis: a review of the evidence, Neuropathol Appl Neurobiol, 27, 257, 10.1046/j.0305-1846.2001.00332.x Wenqenack, 2004, Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model, Brain Res, 1027, 73, 10.1016/j.brainres.2004.08.054 Häggström, 1997, Autoimmunity and ALS: studies on antibodies to acetylcholinesterase in sera, Acta Neurol Scand, 95, 111, 10.1111/j.1600-0404.1997.tb00079.x Kawamata, 1992, Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue, Am J Pathol, 140, 691 McGeer, 2004, Inflammation and the degenerative diseases of aging, Ann NY Acad Sci, 1035, 104, 10.1196/annals.1332.007 Engelhardt, 1993, Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis, Arch Neurol, 50, 30, 10.1001/archneur.1993.00540010026013 Chiu, 2008, T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS, Proc Natl Acad Sci USA, 105, 17913, 10.1073/pnas.0804610105 Holmøy, 2008, T cells in amyotrophic lateral sclerosis, Eur J Neurol, 15, 360, 10.1111/j.1468-1331.2008.02065.x Mosley, 2010, Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders, Exp Neurol, 222, 1, 10.1016/j.expneurol.2009.12.018 Chowdhury, 2008, Death by a thousand cuts: granzyme pathways of programmed cell death, Annu Rev Immunol, 26, 389, 10.1146/annurev.immunol.26.021607.090404 Prakash, 2009, Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement, Immunol Cell Biol, 87, 249, 10.1038/icb.2008.98 Bovenschen, 2010, Orphan granzymes find a home, Immunol Rev, 235, 117, 10.1111/j.0105-2896.2010.00889.x Bunnett, 2006, Protease-activated receptors: how proteases signal to cells to cause inflammation and pain, Semin Thromb Hemost, 32, 39, 10.1055/s-2006-939553 Shpacovitch, 2007, Protease-activated receptors: novel PARtners in innate immunity, Trends Immunol, 28, 541, 10.1016/j.it.2007.09.001 Ashton-Rickardt, 2005, The granule pathway of programmed cell death, Crit Rev Immunol, 25, 161, 10.1615/CritRevImmunol.v25.i3.10 Hendel, 2010, Granzymes in age-related cardiovascular and pulmonary diseases, Cell Death Differ, 17, 596, 10.1038/cdd.2010.5 Buzza, 2006, Extracellular granzymes: current perspectives, Biol Chem, 387, 827, 10.1515/BC.2006.106 Suidan, 1994, Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes, Proc Natl Acad Sci USA, 91, 8112, 10.1073/pnas.91.17.8112 Ebnet, 1995, Granzyme A-deficient mice retain potent cell-mediated cytotoxicity, EMBO J, 14, 4230, 10.1002/j.1460-2075.1995.tb00097.x Matkar, 2008, Human and mouse granzyme A induce a proinflammatory cytokine response, Immunity, 29, 720, 10.1016/j.immuni.2008.08.014 Waterhouse, 2005, A central role for Bid in granzyme B-induced apoptosis, J Biol Chem, 280, 4476, 10.1074/jbc.M410985200 Boivin, 2009, Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma, Lab Invest, 89, 1195, 10.1038/labinvest.2009.91 Kam, 2000, Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors, Biochim Biophys Acta, 1477, 307, 10.1016/S0167-4838(99)00282-4 Brooks, 1994, El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis, J Neurol Sci, 124, 96, 10.1016/0022-510X(94)90191-0 Gordon, 2004, ALSFRS-R, Amyotroph Lateral Scler Other Mot Neuron Disord, 5, 90, 10.1080/17434470410019906 Stanisz, 1998 Anthony, 2010, Functional dissection of the granzyme family: cell death and inflammation, Immunol Rev, 235, 73, 10.1111/j.0105-2896.2010.00907.x Galimberti, 2008, Inflammation in neurodegenerative disorders; friend or foe?, Curr Aging Sci, 1, 30, 10.2174/1874609810801010030 Almer, 2001, Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis, Ann Neurol, 49, 176, 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X Zhou, 2010, Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells, Int Rev Immunol, 29, 38, 10.3109/08830180903247889 Bien, 2002, Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis, Ann Neurol, 51, 311, 10.1002/ana.10100 Bauer, 2002, Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes, Curr Opin Neurol, 15, 197, 10.1097/00019052-200204000-00012 Bauer, 2007, Astrocytes are a specific immunological target in Rasmussen's encephalitis, Ann Neurol, 62, 67, 10.1002/ana.21148 Rossi, 2009, Astrocytic dysfunction: insights on the role in neurodegeneration, Brain Res Bull, 80, 224, 10.1016/j.brainresbull.2009.07.012 Takahashi, 2009, A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells TNFalpha, and Granzyme B in CSF, Epilepsia, 50, 1419, 10.1111/j.1528-1167.2008.01977.x Gelpi, 2006, Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue, J Neurovirol, 12, 322, 10.1080/13550280600848746 Henkel, 2009, Microglia in ALS: the good, the bad, and the resting, J Neuroimmune Pharmacol, 4, 389, 10.1007/s11481-009-9171-5 Kebir, 2007, Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation, Nat Med, 13, 1173, 10.1038/nm1651 Malmestrom, 2008, Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF, J Neuroimmunol, 196, 159, 10.1016/j.jneuroim.2008.03.001 Gobel, 2010, Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack, Glia, 58, 469 Kroner, 2010, Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice, Am J Pathol, 176, 549, 10.2353/ajpath.2010.090722 Jaarsma, 2008, Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice, J Neurosci, 28, 2075, 10.1523/JNEUROSCI.5258-07.2008 Casciola-Rosen, 2008, Granzyme B: evidence for a role in the origin of myasthenia gravis, J Neuroimmunol, 201–202, 33, 10.1016/j.jneuroim.2008.04.041 Niebroj-Dobosz, 2006, Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS), Folia Neuropathol, 44, 191 Chaitanya, 2009, Granzyme-b mediated cell death in the spinal cord-injured rat model, Neuropathology, 29, 270, 10.1111/j.1440-1789.2008.00980.x Skjelland, 2007, Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity, Atherosclerosis, 195, 142, 10.1016/j.atherosclerosis.2007.05.001 Chaitanya, 2010, Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model, Neuroscience, 165, 1203, 10.1016/j.neuroscience.2009.10.067 Lakhan, 2009, Inflammatory mechanisms in ischemic stroke: therapeutic approaches, J Transl Med, 7, 97, 10.1186/1479-5876-7-97 Block, 2009, Air pollution: mechanisms of neuroinflammation and CNS disease, Trends Neurosci, 32, 506, 10.1016/j.tins.2009.05.009